Literature DB >> 18441202

Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion.

Ning Zou1, Lihua Ao, Joseph C Cleveland, Xiaoping Yang, Xin Su, Guang-Yun Cai, Anirban Banerjee, David A Fullerton, Xianzhong Meng.   

Abstract

Previous studies showed that Toll-like receptor 4 (TLR4) modulates the myocardial inflammatory response to ischemia-reperfusion injury, and we recently found that cytokines link TLR4 to postischemic cardiac dysfunction. Although TLR4 can be activated in cultured cells by endogenous agents including heat shock protein 70, how it is activated during myocardial ischemia-reperfusion is unknown. In the present study, we examined 1) whether heat shock cognate protein 70 (HSC70), which is constitutively expressed in the myocardium, is released during ischemia-reperfusion; 2) whether extracellular HSC70 induces the myocardial inflammatory response and modulates cardiac function; and 3) whether HSC70 exerts these effects via TLR4. We subjected isolated mouse hearts to global ischemia-reperfusion via the Langendorff technique. Immunoblotting and immunostaining detected the release of HSC70 from the myocardium during reperfusion. Treatment with an antibody specific to HSC70 suppressed myocardial cytokine expression and improved cardiac functional recovery after ischemia-reperfusion. Recombinant HSC70 induced NF-kappaB activation and cytokine expression and depressed myocardial contractility in a TLR4-dependent manner. These effects required the substrate-binding domain of HSC70. Fluorescence resonance energy transfer analysis of isolated macrophages demonstrated that extracellular HSC70 interacts with TLR4. Therefore, this study demonstrates for the first time that 1) the myocardium releases HSC70 during ischemia-reperfusion, 2) extracellular HSC70 contributes to the postischemic myocardial inflammatory response and to cardiac dysfunction, 3) HSC70 exerts these effects through a TLR4-dependent mechanism, and 4) the substrate-binding domain of HSC70 is required to induce these effects. Thus extracellular HSC70 plays a critical role in regulating the myocardial innate immune response and cardiac function after ischemia-reperfusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18441202      PMCID: PMC3137641          DOI: 10.1152/ajpheart.00299.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  36 in total

1.  High-resolution solution structure of the 18 kDa substrate-binding domain of the mammalian chaperone protein Hsc70.

Authors:  R C Morshauser; W Hu; H Wang; Y Pang; G C Flynn; E R Zuiderweg
Journal:  J Mol Biol       Date:  1999-06-25       Impact factor: 5.469

Review 2.  Release of heat shock proteins (Hsps) and the effects of extracellular Hsps on neural cells and tissues.

Authors:  M Tytell
Journal:  Int J Hyperthermia       Date:  2005-08       Impact factor: 3.914

3.  Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction.

Authors:  B Dybdahl; S A Slørdahl; A Waage; P Kierulf; T Espevik; A Sundan
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

4.  Differential expression of heat shock proteins in normal and failing human hearts.

Authors:  A A Knowlton; S Kapadia; G Torre-Amione; J B Durand; R Bies; J Young; D L Mann
Journal:  J Mol Cell Cardiol       Date:  1998-04       Impact factor: 5.000

5.  Autophagy in chronically ischemic myocardium.

Authors:  Lin Yan; Dorothy E Vatner; Song-Jung Kim; Hui Ge; Malthi Masurekar; William H Massover; Guiping Yang; Yutaka Matsui; Junichi Sadoshima; Stephen F Vatner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-20       Impact factor: 11.205

Review 6.  Innate immunity and the heart.

Authors:  Stefan Frantz; Johann Bauersachs; Ralph A Kelly
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

7.  Association of heat shock proteins and neuronal membrane components with lipid rafts from the rat brain.

Authors:  Sheng Chen; Damanpreet Bawa; Shintaro Besshoh; James W Gurd; Ian R Brown
Journal:  J Neurosci Res       Date:  2005-08-15       Impact factor: 4.164

8.  Signaling for myocardial depression in hemorrhagic shock: roles of Toll-like receptor 4 and p55 TNF-alpha receptor.

Authors:  Xianzhong Meng; Lihua Ao; Yong Song; Christopher D Raeburn; David A Fullerton; Alden H Harken
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-10-28       Impact factor: 3.619

9.  Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.

Authors:  Alexzander Asea; Michael Rehli; Edith Kabingu; Jason A Boch; Olivia Bare; Philip E Auron; Mary Ann Stevenson; Stuart K Calderwood
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

10.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

View more
  46 in total

Review 1.  Heat shock proteins as biomarkers for the rapid detection of brain and spinal cord ischemia: a review and comparison to other methods of detection in thoracic aneurysm repair.

Authors:  James G Hecker; Michael McGarvey
Journal:  Cell Stress Chaperones       Date:  2010-08-30       Impact factor: 3.667

2.  Extracellular heat shock cognate protein 70 induces cardiac functional tolerance to endotoxin: differential effect on TNF-alpha and ICAM-1 levels in heart tissue.

Authors:  Xin Su; Joshua B Sykes; Lihua Ao; Christopher D Raeburn; David A Fullerton; Xianzhong Meng
Journal:  Cytokine       Date:  2010-05-15       Impact factor: 3.861

3.  Transgenic expression of Hsc70 in pancreatic islets enhances autoimmune diabetes in response to beta cell damage.

Authors:  Masih-ul Alam; Julie A Harken; Anna-Maria Knorn; Alisha R Elford; Kip Wigmore; Pamela S Ohashi; Douglas G Millar
Journal:  J Immunol       Date:  2009-10-07       Impact factor: 5.422

4.  Attenuated recovery of contractile function in aging hearts following global ischemia/reperfusion: Role of extracellular HSP27 and TLR4.

Authors:  Lihua Ao; Yufeng Zhai; Chunhua Jin; Joseph C Cleveland; David A Fullerton; Xianzhong Meng
Journal:  Mol Med       Date:  2016-12-19       Impact factor: 6.354

Review 5.  Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine?

Authors:  Emmanuel Lorne; Hervé Dupont; Edward Abraham
Journal:  Intensive Care Med       Date:  2010-08-06       Impact factor: 17.440

6.  Sub-proteomic fractionation, iTRAQ, and OFFGEL-LC-MS/MS approaches to cardiac proteomics.

Authors:  Chad M Warren; David L Geenen; Donald L Helseth; Hua Xu; R John Solaro
Journal:  J Proteomics       Date:  2010-04-12       Impact factor: 4.044

7.  Tissue kallikrein protects against ischemic stroke by suppressing TLR4/NF-κB and activating Nrf2 signaling pathway in rats.

Authors:  Jiawei Yang; Jianhua Su; Fen Wan; Nan Yang; Haibo Jiang; Mingming Fang; Hang Xiao; Jun Wang; Jinrong Tang
Journal:  Exp Ther Med       Date:  2017-06-15       Impact factor: 2.447

8.  Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70.

Authors:  Lihua Ao; Ning Zou; Joseph C Cleveland; David A Fullerton; Xianzhong Meng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-15       Impact factor: 4.733

9.  Isolated hearts treated with skeletal muscle homogenates exhibit altered function.

Authors:  Alex P Di Battista; Marius Locke
Journal:  Cell Stress Chaperones       Date:  2013-03-23       Impact factor: 3.667

Review 10.  Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases.

Authors:  Elaine Lin; Jane E Freedman; Lea M Beaulieu
Journal:  Cardiovasc Ther       Date:  2009       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.